Pleyer Uwe, Geerling Gerd, Schrader Stefan, Jacobi Christina, Kimmich Friedemann, Messmer Elisabeth
Universitäts-Augenklinik, Charité - Campus Virchow-Klinik, Berlin.
Augenklinik, Universitätsklinikum Düsseldorf.
Klin Monbl Augenheilkd. 2020 May;237(5):655-668. doi: 10.1055/a-1115-4756. Epub 2020 May 20.
Dry eye disease (DED) is a heterogenous disease of the ocular surface. Multiple pathogenetic factors are responsible for the disease process, but DED is generally linked to an increase in the osmolarity of the tear film and to inflammation of the ocular surface. The significance of inflammatory processes in DED is highlighted in the most recent definition of dry eye in the Dry Eye Workshop (DEWS). It is therefore critically important for the management of dry eye disease to understand the pathomechanisms and therapeutic options for the treatment of inflammatory processes. This review summarizes our current knowledge on Inflammation associated with DED and provides practical recommendations for the diagnosis and monitoring of the disease, as well as the use of currently available therapeutic options to counteract inflammation in DED.
干眼病(DED)是一种眼表的异质性疾病。多种致病因素参与了该疾病的进程,但干眼病通常与泪膜渗透压升高以及眼表炎症有关。眼表炎症在干眼病中的重要性在干眼研讨会(DEWS)对干眼的最新定义中得到了强调。因此,了解炎症的发病机制和治疗方案对于干眼病的管理至关重要。本综述总结了我们目前对与干眼病相关炎症的认识,并为该疾病的诊断和监测以及使用现有治疗方案对抗干眼病中的炎症提供了实用建议。